About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The work of our group is mainly focused on personalized medicine, including chemical-functional stability studies of drugs in individualized preparations to be administered both orally and parenterally, as well as parenteral nutrition; research focused on the evaluation and/or design of population pharmacokinetic/pharmacodynamic (PK/PD) models and the characterization of the pharmacokinetics of certain drugs of therapeutic interest in the general population or in certain population groups; and research focused on pharmacogenetics and pharmacogenomics. Our research is also focused on advanced interventions: drug evaluation studies (effectiveness, safety and economic studies); and mobile health and telepharmacy.
PMID: 36717307 Journal: NEFROLOGIA Year: 2022 Reference: Nefrologia (Engl Ed). 2022 Sep-Oct;42(5):578-584. doi: 10.1016/j.nefroe.2021.06.010. Epub 2023 Jan 28. Impact factor: Publication type: Paper in international publication Authors: Chamoun, Betty; Gabaldon, Alejandra; Moreso, Francesc; Perello, Manel; Sanchez-Sancho, Pablo; Sellares, Joana; Seron, Daniel; Torres, Irina B et al. DOI: 10.1016/j.nefroe.2021.06.010
PMID: NOPMID0100 Journal: Advances in Laboratory Medicine Year: 2022 Reference: Adv Lab Med / Av en Med Lab. 2022;3(3):263-271. doi:10.1515/almed-2022-0016 Impact factor: Publication type: Paper in national publication Authors: Barquin Del Pino , Raquel ; Benitez Carabante, Maria Isabel ; Casis Saenz, Ernesto; Castellote Bellés, Laura; Ferrer Costa, Roser; López Hellin, Joan; Martinez Sánchez, Luisa; Miarons Font , Marta; Paciucci Barzanti, Rosanna; Rodríguez Frias, Francisco et al. DOI: 10.1515/almed-2022-0016
PMID: 35531306 Journal: Medicina clinica (English ed.) Year: 2022 Reference: Med Clin (Engl Ed). 2022 Apr 8;158(7):301-307. doi: 10.1016/j.medcle.2021.03.036. Epub 2022 May 3. Impact factor: Publication type: Paper in international publication Authors: Berlana, David; Campany-Herrero, David; Cardona-Pascual, Ignacio; Martinez-Valle, Ferran; Montoro-Ronsano, Jose Bruno et al. DOI: 10.1016/j.medcle.2021.03.036
PMID: 35755602 Journal: MEDICINA CLINICA Year: 2022 Reference: Med Clin. 2022 Jun 10;158(11):509-518. doi: 10.1016/j.medcle.2021.06.023. Epub 2022 Jun 18. Impact factor: 1.725 Publication type: Paper in international publication Authors: Sellares-Nadal, Julia; Almirante, Benito; Guillen-Del-Castillo, Alfredo; Sampol, Julia; Augustin, Salvador; Bosch-Nicolau, Pau; Monforte-Pallares, Arnau; Sempere-Gonzalez, Abiu; Eremiev-Eremiev, Simeon; Miarons, Marta et al. DOI: 10.1016/j.medcle.2021.06.023
PMID: 35049519 Journal: European Journal of Hospital Pharmacy Year: 2021 Reference: Eur J Hosp Pharm. 2021 May;28(3):133-138. doi: 10.1136/ejhpharm-2019-002067. Epub 2020 Feb 25. Impact factor: 1.652 Publication type: Paper in international publication Authors: Miarons, Marta, Marin, Sergio, Amenos, Imma, Campins, Lluis, Rovira, Montse, Daza, Manuel et al. DOI: 10.1136/ejhpharm-2019-002067
PMID: 34830495 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 Nov 9;10(22). pii: jcm10225213. doi: 10.3390/jcm10225213. Impact factor: 4.242 Publication type: Paper in international publication Authors: Sempere, Abiu, Salvador, Fernando, Monforte, Arnau, Sampol, Julia, Espinosa-Pereiro, Juan, Miarons, Marta, Bosch-Nicolau, Pau, Guillen-Del-Castillo, Alfredo, Aznar, Maria Luisa, Campos-Varela, Isabel et al. DOI: 10.3390/jcm10225213
PMID: 32997851 Journal: HAEMOPHILIA Year: 2021 Reference: Haemophilia. 2021 Jul;27(4):e473-e475. doi: 10.1111/hae.14160. Epub 2020 Sep 30. Impact factor: 4.287 Publication type: Letter or abstract Authors: Gironella Mesa, Mercedes, Martinez Garcia, Maria Fernanda, Benitez Hidalgo, Olga, Alvarez Martinez, Eva, Juarez Gimenez, Juan-Carlos, Fernandez Sarmiento, Carmen, Suito Alcantara, Milagros, Soto Bonet, Nuria, Cardona Lopez, Raquel, Iacoboni Garcia-Calvo, Gloria et al. DOI: 10.1111/hae.14160
PMID: 34174006 Journal: Transplant Infectious Disease Year: 2021 Reference: Transpl Infect Dis. 2021 Aug;23(4):e13677. doi: 10.1111/tid.13677. Epub 2021 Jul 12. Impact factor: 2.228 Publication type: Letter or abstract Authors: Garcia-Garcia, Sonia, Los-Arcos, Ibai, Moreso, Francesc, Berastegui, Cristina, Castells, Lluis, Gorgas Torner, Maria Q, Miarons, Marta, Larrosa-Garcia, Maria et al. DOI: 10.1111/tid.13677
Within the framework of a clinical trial, the first 3D printed medicine in Europe in the pediatric field will be tested.
